This analysis demonstrates cICB treatment leads to partial transcriptomic convergence of CD8+ T cell gene expression between CMV+ and CMV− patients which is not seen in sICB recipients, indicating the immunological response to ICB in MM depends upon both the patient CMV status and the addition of anti-CTLA-4 treatment. This evidence concerns the gene CD8A and Miyoshi myopathy.